Kevin Church - Oct 28, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Executive VP, Research
Signature
Glenna Mileson, Attorney-in-fact for Kevin Church
Stock symbol
ATHA
Transactions as of
Oct 28, 2022
Transactions value $
$4,995
Form type
4
Date filed
10/31/2022, 08:17 PM
Previous filing
Jun 24, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $5K +3.7K +6.41% $1.35 61.4K Oct 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -3.7K -36.6% $0.00 6.41K Oct 28, 2022 Common Stock 3.7K $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vested on January 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.